Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CXCR2 | P25025 | 2/20 | 0.43 |
| ▸ | CXCR1 | P25024 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.42 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.42 |
| ▸ | CA1 | P00915 | 2/20 | 0.42 |
| ▸ | CA2 | P00918 | 2/20 | 0.42 |
| ▸ | CA9 | Q16790 | 2/20 | 0.42 |
| ▸ | MDM4 | O15151 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | TYR | P14679 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.42 |
| ▸ | CA5A | P35218 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrogen Peroxide SCHEMBL11143418 | 0.98 | CXCR2 (0.46) | CXCR2CXCR1KDM4EALDH1A1SMN1; SMN2 | |
| SCHEMBL1821733 | 0.84 | PTGS1 (0.61) | CXCR2CXCR1KDM4EALDH1A1SMN1; SMN2 | |
| SCHEMBL26452905 | 0.83 | KDM4E (0.43) | KDM4EALDH1A1SMN1; SMN2HDAC4HDAC8 | |
| SCHEMBL28796600 | 0.82 | CXCR2 (0.44) | CXCR2CXCR1CA1CA2DRD2 | |
| SCHEMBL5178160 | 0.82 | CA1 (0.56) | CXCR2CA1CA2CA9DRD2 | |
| SCHEMBL1820336 | 0.81 | PTGS1 (0.53) | CXCR2CXCR1ALDH1A1SMN1; SMN2HTT | |
| SCHEMBL10172546 | 0.79 | CA2 (0.66) | KDM4ECA1CA2CA9TSHR | |
| SCHEMBL16172609 | 0.79 | CXCR2 (0.59) | CXCR2CXCR1ALDH1A1CA1CA2 | |
| SCHEMBL167959 | 0.77 | PPARG (0.54) | ALDH1A1CA1CA2CA9HTT | |
| SCHEMBL451684 | 0.77 | STS (0.47) | ALDH1A1CA1CA2CA9CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240376044-A1 | METHOD FOR PREPARING AROMATIC AMINO ACID DERIVATIVE | CHUGAI PHARMACEUTICAL CO LTD (JP) | 2024-11-14 | — | — | US | disclosed |
| US-12071396-B2 | Method for preparing aromatic amino acid derivative | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2024-08-27 | — | — | US | disclosed |
| US-20220144762-A1 | METHOD FOR PREPARING AROMATIC AMINO ACID DERIVATIVE | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2022-05-12 | — | — | US | disclosed |
| EP-3939962-A1 | METHOD FOR PREPARING AROMATIC AMINO ACID DERIVATIVE | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2022-01-19 | — | — | EP | disclosed |
| CN-113692401-A | Process for producing aromatic amino acid derivative | 中外制药株式会社 | 2021-11-23 | — | — | CN | disclosed |
| WO-2020189540-A1 | METHOD FOR PREPARING AROMATIC AMINO ACID DERIVATIVE | 中外製薬株式会社 | 2020-09-24 | — | — | WO | disclosed |
| CN-1062555-C | Substituted benzyloxy carbonyl guanidine, its prepn. method, and application of the same as medicament and medicament containing the same | HOECHST AG (DE) | 2001-02-28 | — | — | CN | disclosed |
| EP-0748795-B1 | Substituted benzyloxycarbonyl guanidines as Na+/H+ exchange inhibitors, process for their preparation, their use as medicinal or diagnostic agents as well as medicament containing them | HOECHST AG (DE) | 2000-08-23 | — | — | EP | disclosed |
| US-6022899-A | EFFECTIVE INHIBITORS OF THE CELLULAR SODIUM PROTON ANTIPORTER | HOECHST AKTIENGESELLSCHAFT (DE) | 2000-02-08 | — | — | US | disclosed |
| US-5753710-A | INHIBITORS OF THE CELLULAR SODIUM PROTON ANTIPORTER | HOECHST AKTIENGESELLSCHAFT (DE) | 1998-05-19 | — | — | US | disclosed |
| CN-1145360-A | Substituted benzyloxy carbonyl guanidine, its prepn. method, and application of the same as medicament and medicament containing the same | HOECHST AG (DE) | 1997-03-19 | — | — | CN | disclosed |
| EP-0748795-A2 | Substituted benzyloxycarbonyl guanidines as Na+/H+ exchange inhibitors, process for their preparation, their use as medicinal or diagnostic agents as well as medicament containing them | HOECHST AKTIENGESELLSCHAFT (DE) | 1996-12-18 | — | — | EP | disclosed |
| US-4424382-A | Superacid catalyzed preparation of resorcinol from meta-isopropylepheol | PCUK PRODUITS CHIMIQUES UGINE KUHLMANN (FR) | 1984-01-03 | — | — | US | disclosed |
| US-4423254-A | Superacid catalyzed preparation of resorcinol from meta-isopropylphenol | PCUK PRODUITS CHIMIQUES UGINE KUHLMANN (FR) | 1983-12-27 | — | — | US | disclosed |
| US-4339614-A | Superacid catalyzed preparation of resorcinol from meta-isopropylphenol | PCUK PRODUITS CHIMIQUES UGINE KUHLMANN (FR) | 1982-07-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240376044-A1 | METHOD FOR PREPARING AROMATIC AMINO ACID DERIVATIVE | DDC, AADAT, TYR | CXCR2 4458/4885CXCR1 3889/4885KDM4E 626/4885 |
| US-20220144762-A1 | METHOD FOR PREPARING AROMATIC AMINO ACID DERIVATIVE | DDC, AADAT, TYR | CXCR2 4458/4885CXCR1 3889/4885KDM4E 626/4885 |
| US-12071396-B2 | Method for preparing aromatic amino acid derivative | DDC, AADAT, TYR | CXCR2 4458/4885CXCR1 3889/4885KDM4E 626/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.